Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
 |
Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed
Dec 31, 2009
|
8.8 KB
|
| |
SOUTH SAN FRANCISCO, Dec 31, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that it was unable to satisfy the closing conditions set forth in the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation, a wholly-owned subsidiary of Anesiva, Arcion Therapeut...
|
|
 |
Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals
Dec 9, 2009
|
8.9 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Dec 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that on December 3, 2009, Anesiva entered into an Asset Purchase Agreement which assigned its rights under the Revised License Agreement with PowderJect Technologies, Ltd., dated November 30, 2009, and sold certai...
|
|
 |
Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions
Dec 8, 2009
|
9.3 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Dec 08, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that the stockholders of Anesiva approved the merger with Arcion Therapeutics, Inc. ("Arcion") during its December 3, 2009 shareholder meeting. In connection with the merger, Anesiva stockholders also approved a ...
|
|
 |
Anesiva Receives NASDAQ Listing Compliance Notice
Dec 8, 2009
|
9.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Dec 08, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that on December 2, 2009, Anesiva received a letter from The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $5,000,000 during...
|
|
 |
Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger
Nov 23, 2009
|
11.3 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Nov 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that Dr. Ted W. Love and Dr. David C. U'Prichard have agreed to join the Anesiva board of directors following completion of the proposed merger between Anesiva and Arcion Therapeutics. Completion of the merger is ...
|
|
|